| Product Code: ETC7536153 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India advanced parenteral drug market import shipment experienced a notable decline with a CAGR of -13.8% from 2020 to 2024. However, the rate of decline moderated slightly between 2023 and 2024, indicating a potential stabilization in the market's contraction. The overall trend suggests a slowdown in import growth over the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Advanced Parenteral Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Advanced Parenteral Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Advanced Parenteral Drug Market - Industry Life Cycle |
3.4 India Advanced Parenteral Drug Market - Porter's Five Forces |
3.5 India Advanced Parenteral Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India Advanced Parenteral Drug Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 India Advanced Parenteral Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India |
4.2.2 Growing demand for advanced drug delivery systems |
4.2.3 Rising investments in healthcare infrastructure and RD |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of advanced parenteral drugs |
4.3.2 High cost associated with advanced parenteral drugs |
4.3.3 Limited awareness and adoption of advanced parenteral drug therapies |
5 India Advanced Parenteral Drug Market Trends |
6 India Advanced Parenteral Drug Market, By Types |
6.1 India Advanced Parenteral Drug Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India Advanced Parenteral Drug Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 India Advanced Parenteral Drug Market Revenues & Volume, By Government Hospitals, 2021- 2031F |
6.1.4 India Advanced Parenteral Drug Market Revenues & Volume, By Private Hospitals and Clinics, 2021- 2031F |
6.1.5 India Advanced Parenteral Drug Market Revenues & Volume, By Healthcare Organizations, 2021- 2031F |
6.1.6 India Advanced Parenteral Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Advanced Parenteral Drug Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 India Advanced Parenteral Drug Market Revenues & Volume, By Prefillable Syringes, 2021- 2031F |
6.2.3 India Advanced Parenteral Drug Market Revenues & Volume, By Injectors Cartridges, 2021- 2031F |
6.2.4 India Advanced Parenteral Drug Market Revenues & Volume, By Hypodermic Syringes, 2021- 2031F |
6.2.5 India Advanced Parenteral Drug Market Revenues & Volume, By IV Catheters, 2021- 2031F |
7 India Advanced Parenteral Drug Market Import-Export Trade Statistics |
7.1 India Advanced Parenteral Drug Market Export to Major Countries |
7.2 India Advanced Parenteral Drug Market Imports from Major Countries |
8 India Advanced Parenteral Drug Market Key Performance Indicators |
8.1 Research and development expenditure in advanced drug delivery technologies |
8.2 Number of clinical trials for advanced parenteral drugs in India |
8.3 Adoption rate of advanced parenteral drug therapies in major healthcare facilities |
8.4 Percentage of healthcare professionals trained in administering advanced parenteral drugs |
9 India Advanced Parenteral Drug Market - Opportunity Assessment |
9.1 India Advanced Parenteral Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India Advanced Parenteral Drug Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 India Advanced Parenteral Drug Market - Competitive Landscape |
10.1 India Advanced Parenteral Drug Market Revenue Share, By Companies, 2024 |
10.2 India Advanced Parenteral Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here